Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Modafinil binds to the dopamine uptake carrier site with low affinity.

Mignot E, Nishino S, Guilleminault C, Dement WC.

Sleep. 1994 Aug;17(5):436-7. No abstract available.

PMID:
7991954
2.

[Modafinil: pharmacology and therapeutic perspectives].

Billiard M.

Rev Neurol (Paris). 2003 Jan;159(1):122-5. Review. French. No abstract available.

PMID:
12618664
3.

Neuroadaptations involved in amphetamine and cocaine addiction.

White FJ, Kalivas PW.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):141-53. Review. No abstract available.

PMID:
9716936
4.

Dopamine receptors in Parkinson's disease: imaging studies.

Stoessl AJ, de la Fuente-Fernández R.

Adv Neurol. 2003;91:65-71. Review. No abstract available.

PMID:
12442664
6.

Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.

Myrick H, Malcolm R, Taylor B, LaRowe S.

Ann Clin Psychiatry. 2004 Apr-Jun;16(2):101-9. Review.

PMID:
15328903
7.

What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.

Boutrel B, Koob GF.

Sleep. 2004 Sep 15;27(6):1181-94. Review.

PMID:
15532213
8.

Compound narcolepsy: development of biochemical imbalance.

Smith KM, Cohen FL.

Int J Neurosci. 1988 Oct;42(3-4):229-52. Review.

PMID:
2905344
9.

Neural systems underlying arousal and attention. Implications for drug abuse.

Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ.

Ann N Y Acad Sci. 1998 Jun 21;846:222-37. Review.

PMID:
9668410
10.

Dopamine receptor subtypes and arousal.

Ongini E, Longo VG.

Int Rev Neurobiol. 1989;31:239-55. Review. No abstract available.

PMID:
2689381
Items per page

Supplemental Content

Write to the Help Desk